The Board of Directors at Aster DM Healthcare approved the unaudited financial results for the quarter and nine months ending December 31, 2025. Additionally, they approved the ESOP Scheme 2026, granting options to eligible employees pending shareholder approval. The board also approved converting an inter-corporate loan into equity shares of Aster DM Multispecialty Hospital Private Limited. It gave a go-ahead for granting loans and providing guarantees to group companies.
Financial Results Approved
Aster DM Healthcare’s Board has approved the unaudited financial results for Q3 2026 and the nine months ending December 31, 2025. The financial results were reviewed by the Audit Committee before Board approval. The statutory auditor, Deloitte Haskins & Sells, issued an unmodified opinion on the results.
ESOP Scheme 2026 Launch
The Board also approved the ESOP Scheme 2026. This scheme allows the grant of options to eligible employees across the company and its unlisted subsidiaries and holding company, subject to shareholder approval.
Loan Conversion Approved
An inter-corporate loan to Aster DM Multispecialty Hospital Private Limited, a wholly-owned subsidiary, will be converted into equity. A loan of ₹129.35 Cr will be converted, with Aster DM Multispecialty Hospital issuing 12,93,45,537 equity shares to Aster DM Healthcare. Additionally, a shareholders’ agreement was entered into. This restructuring does not impact ownership or control.
Other Approvals
The Board approved granting loans, giving guarantees, or providing securities to group companies, as permitted under Section 185 of the Companies Act, 2013. It also approved keeping statutory registers and returns at the Corporate Office in Bengaluru.
Financial Performance Details
The unaudited standalone financial results show a total income of ₹697.16 crores for the quarter ended December 31, 2025. Profit for the period stood at ₹55.16 crores. Basic earnings per share were reported at ₹1.07.
Consolidated Results Highlights
The unaudited consolidated financial results reveal a total income of ₹1,213.73 crores for the quarter ended December 31, 2025, and a profit for the period of ₹58.65 crores. Basic earnings per share from continuing operations were ₹1.02.
Additional Notes
The Company shifted its registered office from Karnataka to Telangana. 507,500 options were granted under the Employee Stock Option Plan 2013. An additional stake in Prerana Hospital Limited (Aster Aadhar) was acquired, increasing shareholding to 98.92%.
Source: BSE
